TriSalus Life Sciences (TLSI) Competitors $4.07 -0.05 (-1.21%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TLSI vs. TMCI, CATX, TCMD, ZIMV, RCEL, SMLR, NNOX, CVRX, SMTI, and DCTHShould you be buying TriSalus Life Sciences stock or one of its competitors? The main competitors of TriSalus Life Sciences include Treace Medical Concepts (TMCI), Perspective Therapeutics (CATX), Tactile Systems Technology (TCMD), ZimVie (ZIMV), AVITA Medical (RCEL), Semler Scientific (SMLR), Nano-X Imaging (NNOX), CVRx (CVRX), Sanara MedTech (SMTI), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. TriSalus Life Sciences vs. Treace Medical Concepts Perspective Therapeutics Tactile Systems Technology ZimVie AVITA Medical Semler Scientific Nano-X Imaging CVRx Sanara MedTech Delcath Systems Treace Medical Concepts (NASDAQ:TMCI) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, community ranking, media sentiment, risk, analyst recommendations, valuation and institutional ownership. Do insiders and institutionals hold more shares of TMCI or TLSI? 84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 2.6% of TriSalus Life Sciences shares are owned by institutional investors. 24.4% of Treace Medical Concepts shares are owned by insiders. Comparatively, 32.8% of TriSalus Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community believe in TMCI or TLSI? Treace Medical Concepts received 14 more outperform votes than TriSalus Life Sciences when rated by MarketBeat users. However, 100.00% of users gave TriSalus Life Sciences an outperform vote while only 47.06% of users gave Treace Medical Concepts an outperform vote. CompanyUnderperformOutperformTreace Medical ConceptsOutperform Votes2447.06% Underperform Votes2752.94% TriSalus Life SciencesOutperform Votes10100.00% Underperform VotesNo Votes Is TMCI or TLSI more profitable? Treace Medical Concepts has a net margin of -30.33% compared to TriSalus Life Sciences' net margin of -206.24%. TriSalus Life Sciences' return on equity of 0.00% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets Treace Medical Concepts-30.33% -51.12% -26.36% TriSalus Life Sciences -206.24%N/A -236.83% Does the media prefer TMCI or TLSI? In the previous week, TriSalus Life Sciences had 10 more articles in the media than Treace Medical Concepts. MarketBeat recorded 11 mentions for TriSalus Life Sciences and 1 mentions for Treace Medical Concepts. TriSalus Life Sciences' average media sentiment score of 0.38 beat Treace Medical Concepts' score of 0.25 indicating that TriSalus Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral TriSalus Life Sciences 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, TMCI or TLSI? Treace Medical Concepts has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500. Comparatively, TriSalus Life Sciences has a beta of 0.49, meaning that its share price is 51% less volatile than the S&P 500. Which has stronger valuation & earnings, TMCI or TLSI? Treace Medical Concepts has higher revenue and earnings than TriSalus Life Sciences. Treace Medical Concepts is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreace Medical Concepts$187.12M2.66-$49.53M-$0.99-8.06TriSalus Life Sciences$18.51M6.70-$59.04M-$2.49-1.63 Do analysts prefer TMCI or TLSI? Treace Medical Concepts presently has a consensus target price of $7.40, suggesting a potential downside of 7.27%. TriSalus Life Sciences has a consensus target price of $12.08, suggesting a potential upside of 196.89%. Given TriSalus Life Sciences' stronger consensus rating and higher possible upside, analysts plainly believe TriSalus Life Sciences is more favorable than Treace Medical Concepts.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treace Medical Concepts 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00TriSalus Life Sciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25 SummaryTriSalus Life Sciences beats Treace Medical Concepts on 12 of the 19 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get TriSalus Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLSI vs. The Competition Export to ExcelMetricTriSalus Life SciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$125.62M$4.47B$5.07B$8.90BDividend YieldN/A36.79%4.99%4.07%P/E Ratio-1.6313.2787.8613.46Price / Sales6.7044.831,228.8287.66Price / CashN/A52.2739.5136.27Price / Book-6.075.776.946.30Net Income-$59.04M$13.76M$119.12M$225.93M7 Day Performance1.50%-1.10%-1.84%-1.32%1 Month Performance-4.24%0.56%-3.65%0.60%1 Year Performance9.12%50.90%31.64%26.23% TriSalus Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLSITriSalus Life Sciences4.2803 of 5 stars$4.07-1.2%$12.08+196.9%+9.1%$125.62M$18.51M-1.63106TMCITreace Medical Concepts1.0224 of 5 stars$7.98+2.8%$7.40-7.3%-7.1%$483.42M$187.12M0.00250CATXPerspective Therapeutics2.7597 of 5 stars$6.16-9.1%$21.57+250.2%N/A$458.24M$1.43M0.00116Analyst RevisionTCMDTactile Systems Technology3.7846 of 5 stars$15.56-1.3%$23.00+47.8%+23.1%$378.43M$274.42M23.94980ZIMVZimVie2.5824 of 5 stars$13.49+2.4%$18.33+35.9%+49.2%$363.48M$457.43M0.002,600RCELAVITA Medical1.4051 of 5 stars$13.05+0.7%$16.50+26.4%+4.1%$339.78M$50.14M0.00130SMLRSemler Scientific1.0709 of 5 stars$59.27+27.9%N/A+60.6%$336.72M$68.18M28.9192Gap UpHigh Trading VolumeNNOXNano-X Imaging1.7461 of 5 stars$5.89+3.5%$14.00+137.7%-10.5%$328.76M$9.90M0.00190CVRXCVRx2.0918 of 5 stars$13.52+0.7%$15.83+17.1%-25.8%$325.62M$39.29M0.00200SMTISanara MedTech1.2253 of 5 stars$37.28+0.9%$44.00+18.0%+17.2%$322.99M$64.99M0.0060Gap UpHigh Trading VolumeDCTHDelcath Systems3.5248 of 5 stars$9.63-2.8%$21.50+123.3%+256.7%$316.86M$2.07M0.0076 Related Companies and Tools Related Companies Treace Medical Concepts Competitors Perspective Therapeutics Competitors Tactile Systems Technology Competitors ZimVie Competitors AVITA Medical Competitors Semler Scientific Competitors Nano-X Imaging Competitors CVRx Competitors Sanara MedTech Competitors Delcath Systems Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TLSI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TriSalus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TriSalus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
